FBXO11 Antibodies

Santa Cruz Biotechnology features a diverse variety of FBXO11 monoclonal antibodies for investigating FBXO11's role in cellular processes. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FBXO11 is a member of the F-box protein family, which plays a key role in the ubiquitin-proteasome pathway, regulating protein degradation and turnover. FBXO11 participates in various cellular functions, including cell cycle regulation, apoptosis, and transcriptional control, making it essential for maintaining cellular homeostasis. Research has shown that FBXO11 alterations can contribute to several diseases, including cancer, highlighting its significance as a potential therapeutic target. Understanding FBXO11's molecular mechanisms and cellular functions can provide crucial insights into disease development and progression. Investigating FBXO11's interactions with other proteins helps reveal its regulatory networks and signaling pathways. Exploring FBXO11's role in different tissue types can uncover its tissue-specific functions and disease associations. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of FBXO11's biological significance and therapeutic potential.